5 Mechanism based targeted therapy for hereditary...

European Journal of Cancer 2014 / 11 Vol. 50

5 Mechanism based targeted therapy for hereditary leiomyomatosis and renal cell cancer (HLRCC) and sporadic papillary renal cell carcinoma: interim results from a phase 2 study of bevacizumab and erlotinib

Srinivasan, R., Su, D., Stamatakis, L., Siddiqui, M.M., Singer, E., Shuch, B., Nix, J., Friend, J., Hawks, G., Shih, J., Choyke, P., Linehan, W.M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70131-5
Date:
November, 2014
File:
PDF, 56 KB
english, 2014
Conversion to is in progress
Conversion to is failed